Report cover image

North America Veterinary Pain Management Market Size, Share & Industry Trends Analysis Report By Animal type (Livestock Animal and Companion Animal), By End-Use, By Indication, By Product, By Country and Growth Forecast, 2023 - 2030

Publisher Knowledge Based Value (KBV) Research
Published Aug 31, 2023
Length 125 Pages
SKU # KBV18252015

Description

North America Veterinary Pain Management Market Size, Share & Industry Trends Analysis Report By Animal type (Livestock Animal and Companion Animal), By End-Use, By Indication, By Product, By Country and Growth Forecast, 2023 - 2030


The North America Veterinary Pain Management Market would witness market growth of 5.5% CAGR during the forecast period (2023-2030).

Veterinary treatment must have effective pain management. When pain is not properly managed in animals, sick animals experience increased stress and delayed healing. Animals may experience pain from operation, arthritis, or cancer, accompanied by discrimination, starvation, and reduced activity. This may hamper the productivity of agricultural and companion animals. Due to ongoing research on reducing chronic pain in animals, numerous methods are now available, including painkillers, physical therapy, acupuncture, laser therapy, and therapeutic massage.

Due to the rise in pet adoption as companions, which raises the demand for preventative care, medications, and veterinary healthcare facilities, the market has been expanding significantly. The prevalence of animal diseases that cause discomfort and inflammation is another factor driving market expansion. Additionally, it is projected that the increasing popularity of alternative and non-pharmaceutical treatments and untapped growing markets would offer additional growth opportunities.

The market in the North America region is anticipated to expand due to factors including growing adoption of pets and rising per capita spending on veterinary treatment for animals in the region. The primary cause of the market's expansion has been recognized as the increase in the occurrence of numerous animal diseases and injuries. The number of pets and livestock owners in the US has increased, and people have become more aware of the welfare of these animals. Therefore, the market is anticipated to experience considerable growth over the forecast period in North America due to the increasing awareness of and spending on animal health. The prevalence of inflammatory disorders in animals is increasing, along with all of the above factors; thus, the market is projected to expand over the coming years.

The US market dominated the North America Veterinary Pain Management Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $625 million by 2030. The Canada market is poised to grow at a CAGR of 7.9% during (2023 - 2030). Additionally, The Mexico market would witness a CAGR of 6.9% during (2023 - 2030).

Based on Animal type, the market is segmented into Livestock Animal and Companion Animal. Based on End-Use, the market is segmented into Hospitals & Clinics and Others. Based on Indication, the market is segmented into Osteoarthritis, Post-operative pain, and Others. Based on Product, the market is segmented into NSAIDs, Opioids, Anesthetics and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Bayer AG, Zoetis, Inc., Merck & Co., Inc., Elanco Animal Health, Inc., Zomedica Corp. (Assisi Animal Health), Norbrook Laboratories Limited, Ceva Santé Animale, Dechra Pharmaceuticals PLC, and Vetoquinol SA (Soparfin SCA)

Scope of the Study

Market Segments covered in the Report:

By Animal type
  • Livestock Animal
  • Companion Animal
By End-Use
  • Hospitals & Clinics
  • Others
By Indication
  • Osteoarthritis
  • Post-operative pain
  • Others
By Product
  • NSAIDs
  • Opioids
  • Anesthetics
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • Boehringer Ingelheim International GmbH
  • Bayer AG
  • Zoetis, Inc.
  • Merck & Co., Inc.
  • Elanco Animal Health, Inc.
  • Zomedica Corp. (Assisi Animal Health)
  • Norbrook Laboratories Limited
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Vetoquinol SA (Soparfin SCA)
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

125 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Veterinary Pain Management Market, by Animal type
1.4.2 North America Veterinary Pain Management Market, by End-Use
1.4.3 North America Veterinary Pain Management Market, by Indication
1.4.1 North America Veterinary Pain Management Market, by Product
1.4.2 North America Veterinary Pain Management Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Veterinary pain management Market
Chapter 5. North America Veterinary Pain Management Market by Animal type
5.1 North America Livestock Animal Market by Country
5.2 North America Companion Animal Market by Country
Chapter 6. North America Veterinary Pain Management Market by End-use
6.1 North America Hospitals & Clinics Market by Country
6.2 North America Others Market by Country
Chapter 7. North America Veterinary Pain Management Market by Indication
7.1 North America Osteoarthritis Market by Country
7.2 North America Post-operative pain Market by Country
7.3 North America Others Market by Country
Chapter 8. North America Veterinary Pain Management Market by Product
8.1 North America NSAIDs Market by Country
8.2 North America Opioids Market by Country
8.3 North America Anesthetics Market by Country
8.4 North America Others Market by Country
Chapter 9. North America Veterinary Pain Management Market by Country
9.1 US Veterinary Pain Management Market
9.1.1 US Veterinary Pain Management Market by Animal type
9.1.2 US Veterinary Pain Management Market by End-use
9.1.3 US Veterinary Pain Management Market by Indication
9.1.4 US Veterinary Pain Management Market by Product
9.2 Canada Veterinary Pain Management Market
9.2.1 Canada Veterinary Pain Management Market by Animal type
9.2.2 Canada Veterinary Pain Management Market by End-use
9.2.3 Canada Veterinary Pain Management Market by Indication
9.2.4 Canada Veterinary Pain Management Market by Product
9.3 Mexico Veterinary Pain Management Market
9.3.1 Mexico Veterinary Pain Management Market by Animal type
9.3.2 Mexico Veterinary Pain Management Market by End-use
9.3.3 Mexico Veterinary Pain Management Market by Indication
9.3.4 Mexico Veterinary Pain Management Market by Product
9.4 Rest of North America Veterinary Pain Management Market
9.4.1 Rest of North America Veterinary Pain Management Market by Animal type
9.4.2 Rest of North America Veterinary Pain Management Market by End-use
9.4.3 Rest of North America Veterinary Pain Management Market by Indication
9.4.4 Rest of North America Veterinary Pain Management Market by Product
Chapter 10. Company Profiles
10.1 Boehringer Ingelheim International Gmbh
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional & Segmental Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.6 SWOT Analysis
10.2 Bayer AG
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 SWOT Analysis
10.3 Zoetis, Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Acquisition and Mergers:
10.3.5.2 Trail and Approvals:
10.3.6 SWOT Analysis
10.4 Merck & Co., Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 SWOT Analysis
10.5 Elanco Animal Health, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.5.5.2 Product Launches and Product Expansions:
10.5.5.3 Acquisition and Mergers:
10.5.6 SWOT Analysis
10.6 Zomedica Corp. (Assisi Animal Health)
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental Analysis
10.6.4 Research & Development Expenses
10.6.5 SWOT Analysis
10.7 Norbrook Laboratories Limited
10.7.1 Company Overview
10.7.2 SWOT Analysis
10.8 Ceva Sante Animale
10.8.1 Company Overview
10.8.2 SWOT Analysis
10.9 Dechra Pharmaceuticals PLC
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental & Regional Analysis
10.9.4 Research & Development Expenses
10.9.5 Recent strategies and developments:
10.9.5.1 Acquisition and Mergers:
10.9.6 SWOT Analysis
10.10. Vetoquinol SA (Soparfin SCA)
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 SWOT Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us